People | January 03, 2025
Abbott India appoints Prithwish K Banerji as Commercial Director - Women’s Health, Metabolics and International Business
Prithwish has close to 28 years of experience in a Commercial role
Prithwish has close to 28 years of experience in a Commercial role
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Esketamine hydrochloride is a vital drug to be used for treating mental illness and is likely to significantly impact the LATAM market
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
He did Master’s of Pharmacy (Pharmaceutical Technology, Formulations) from National Institute of Pharmaceutical Education and Research, Mohali and Bachelor of Pharmacy from Osmania University
Construction of the plant will commence in 2025 with first production expected to be in 2027
The US District Court of New Jersey decided to grant a preliminary injunction delaying the launch of LEQSELVI
Akums Drugs will undertake this development and commercialization in India
Mylan and Novo Nordisk reach settlement of US patent litigation related to Ozempic
Takeda has granted Lupin non-exclusive patent licensing rights to commercialize Vonoprazan in India
Subscribe To Our Newsletter & Stay Updated
